Pediatric Neuroscience Symposium

Children with Neurological and Neurosurgical Conditions: An Update for Pediatricians

In this virtual course, available from September 1-30, leading specialists in pediatric neurosurgery and pediatric neurology will provide an update on the latest advances in management and treatment options for patients with pediatric neurological conditions. The activity contains 10 presentations that are designed for physicians in pediatric, general, and family practice, pediatric neurologists, nurses, as well as physical, speech, and occupational therapists.

This activity has been approved for AMA PRA Category 1 Credit™. More information regarding additional credits to come soon!

General Information

Up to 3.5 AMA PRA Category 1 Credits
Release Date: September 1, 2021
Expiration Date: September 30, 2021
Format: Internet-based Video
Registration Fees: Complimentary

Statement of Purpose

In this virtual course, available from September 1-30, leading specialists in pediatric neurosurgery and pediatric neurology will provide an update on the latest advances in management and treatment options for patients with pediatric neurological conditions. The activity contains 10 presentations that are designed for physicians in pediatric, general, and family practice, pediatric neurologists, nurses, as well as physical, speech, and occupational therapists.

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Identify which patients may benefit from Child Neurology referral: Urgent vs low-risk.
  • Review mechanisms to improve Child Neurology availability in the community.
  • Define febrile seizures, classification of febrile seizures, risk factors for recurrent febrile seizures and epilepsy, and initial diagnosis.
  • Discuss management of febrile and new onset seizures.
  • Identify which pediatric epilepsy patients may benefit from referral for additional workup.
  • Understand craniosynostosis pathophysiology and indications for treatment.
  • Identify patients who are appropriate for specific craniosynostosis treatment strategies.
  • Identify which incidental findings on imaging studies require urgent or routine referral to a pediatric neurosurgeon.
  • Identify which incidental findings on imaging studies require reassurance only without referral to a pediatric neurosurgeon.
  • Review the presentation of Moya-Moya Disease and discuss treatment options.
  • Identify the signs, symptoms, and test results that should prompt urgent referral to pediatric neurology for evaluation for neuromuscular disorders.
  • Discuss the potential adverse outcomes related to delayed diagnosis and treatment of neuromuscular disorders.
  • Review neurogenetics, the nervous system and diagnosis and management of these disorders.
  • Review and discuss the expanding neurosurgical entities that now encompass the age ranges from fetus to adulthood.
  • Determine why the primary care provider becomes the pivot point for assuring good outcomes even years and decades after the operation has been performed.
  • Review introductory diagnosis, counseling and basic background of plexus injuries.
  • Review components of physical exam and diagnosis of plexus injuries.
  • Discuss utility of imaging/work-up testing, and indications and options for surgery for plexus injuries.

Target Audience:

This activity is designed for Pediatric Neurosurgeons, Pediatric Neurologists, Pediatricians, Physical Therapists, Occupational Therapists and Nurses.

CME/CE Credit

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Antidote Education Company, Children’s Memorial Hermann Hospital and UTHealth Neurosciences. Antidote is accredited by the ACCME to provide continuing medical education for physicians.

Antidote designates this internet enduring activity for a maximum of 3.5 AMA PRA Category 1 Credits™.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses
This nursig continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.

PT: Memorial Hermann Health System is a Texas Physical Therapy Association (TPTA) Accredited Provider of continuing education. This activity is provided by the Texas Board of Physical Therapy Examiners Accredited Provider 2207019TX and meets continuing competence requirements for physical therapist and physical therapist assistant licensure renewal in Texas.  The assignment of Texas PT CCUs does not imply endorsement of specific course content, products, or clinical procedures by TPTA or TBPTE.

  • TPTA CCUs: 3.0
  • TPTA requires PT Participants MUST ATTEND ENTIRE COURSE in order to receive CEUs / CCUs and course certificate. No partial credits given.

OT: Memorial Hermann Health System is an American Occupational Therapy Association (AOTA) Approved Provider of continuing education (CEU). The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures from AOTA.

  • AOTA CEUs: 0.3
  • Contact hours:  3.0
  • AOTA Category: Foundational Knowledge
  • AOTA Instructional Level:  Intermediate
  • AOTA Approval Code: 2952
  • OT Participants MUST ATTEND ENTIRE COURSE in order to receive CEUs / CCUs and course certificate. No partial credits given.

AOTA-Approved Provider Program

Sessions

Neonatal Brachial Plexus Injury
Wendy Chen, MD  

Febrile Seizures and New Onset Seizures in Children – Initial Diagnosis and Management for Pediatricians
Indira Kommuru, MD

Neurosurgery from Fetal Neurosurgery to Adulthood: Why Primary Care is a Pivotal Point for Good Outcomes
Stephen Fletcher, DO

Pediatric Traumatic Brain Injury
Brandon Miller, MD

Weakness in Children – What to Do and When to Refer
Shade Moody, MD

What’s New in Craniosynostosis
Phuong Nguyen, MD

Neurogenetics
Nick Russo, MD

Incidental Findings on MRI and CT Scans of the Brain in Children – When Should I Worry?
David Sandberg, MD

Update on Pediatric Epilepsy Surgery
Manish Shah, MD

Child Neurology in the Community:  Who Should be Referred?
Shaun Varghese, MD

Method of Participation

  • Read the learning objectives and faculty disclosures.
  • Click on the link below to participate in the online activity.
  • Complete the post-test and evaluation presented at the end of the activity.
  • Learners who complete at least one module and the activity evaluation by September 30, 2021 will receive a statement of credit. Learners do not need to complete all the modules to earn credit. The credit earned will be commensurate with participation.

Course Directors

David I. Sandberg, MD, FAANS, FACS, FAAP
Professor and Director of Pediatric Neurosurgery
Dr. Marnie Rose Professor in Pediatric Neurosurgery
Departments of Pediatric Surgery and Neurosurgery
McGovern Medical School at UTHealth
Children’s Memorial Hermann Hospital and Mischer Neuroscience Institute

Gretchen K. Von Allmen, MD, FACNS
Professor, Department of Pediatrics, Division of Child Neurology
Professor, Department of Neurology
Director, Pediatric Epilepsy Program
Chief of the Division of Child Neurology, Department of Pediatrics
McGovern Medical School and UTHealth

Planning Committee

David I. Sandberg, MD, FAANS, FACS, FAAP
Professor, Department of Pediatric Surgery and Vivian L. Smith Department of Neurosurgery, McGovern Medical School
Director, Pediatric Neurosurgery, Children’s Memorial Hermann Hospital

Gretchen K. Von Allmen, MD, FACNS
Professor and Chief of the Division of Child Neurology, Department of Pediatrics
Professor, Department of Neurology
Director, Pediatric Epilepsy Program

Vianey Leang, MSN, RN
Clinical Nurse Coordinator, McGovern Medical School

Anne Crocker
Physician Liaison, UTHealth Neurosciences, McGovern Medical School

Hilary Katulak
Marketing Manager, UTHealth Neurosciences, McGovern Medical School

Alisse Pratt
Marketing Director, UTHealth Neurosciences, McGovern Medical School

Identification and Mitigation of Conflicts of Interest

In accordance with The Standards for Integrity and Independence in Accredited Continuing Education promulgated by the Accreditation Council for Continuing Medical Education (“ACCME”), it is the policy of Antidote Education Company that all individuals in a position to control the content of an activity disclose all financial relationships with any ineligible company to Antidote prior to the activity.  A relevant financial relationship is defined as any financial relationship in any amount occurring within the past 24 months that creates a conflict of interest.  A conflict of interest exists when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he or she has a financial relationship.  Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Antidote has established mechanisms to mitigate any conflicts of interest disclosed or otherwise identified to ensure independence in all of its educational activities.  If, through the application of these mechanisms, an individual’s conflict of interest cannot be resolved, that individual is prohibited from participating in the activity in question in any manner.

The conflicts of interest, if any, of the individuals in a position to control the content of this educational activity have been mitigated through Antidote’s conflict resolution mechanism.  Nonetheless, the relevant financial relationships, if any, of each individual in a position to control the content of this educational activity have been disclosed to you in the following section of this handout entitled “Disclosures.”  If an individual has no relevant financial relationships, that fact is also provided to you.

The following individuals have indicated no conflicts of interest to disclosure:

Disclosures

Individuals in a position to control the content of this CME activity reported the following relevant financial relationships with ineligible companies:

Wendy Chen, MD – Consultant (Allergan)

Gretchen Von Allmen, MD, Indira Kommuru, MD, Stephen Fletcher, DO, Brandon Miller, MD, Shade Moody, MD, Phuong Nguyen, MD, Nick Russo, MD, David Sandberg, MD, Manish Shah, MD, Shaun Varghese, MD, David I. Sandberg, MD, Vianey Leang, MSN, RN, Anne Crocker, Hilary Katulak, Alisse Pratt, Matthew Fleming and Michael Fleming, MD have disclosed that they have no conflicts of interest.

Disclaimer

The material presented in this course is being made available by Antidote Education Company, Children’s Memorial Hermann Hospital and UTHealth Neurosciences for educational purposes only. This material is not intended to represent the best or only methods or procedures appropriate for the medical situations discussed, but rather is intended to present an approach, view, statement or opinion of the faculty which may be helpful to others who face similar situations. Opinions expressed in this activity are those of the faculty and not of Antidote.

Every effort has been made to assure the accuracy of the data presented at this course. Physicians may care to check specific details such as drug doses and contraindications in standard sources prior to clinical application.

Off-label or Investigational Use

The planners and presenters indicated that no off-label or investigational use would be discussed in this activity.

Privacy Policy

View our privacy policy here.